Clinical trials
Phase 3 Neoplasms trials in Serbia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 4 |
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 3 |
| Grünenthal GmbH | 2 |
| Hoffmann-La Roche | 2 |
| Tris Pharma, Inc. | 2 |
| Amgen | 1 |
| Bayer | 1 |
| Centus Biotherapeutics Limited | 1 |
| Genmab | 1 |
| Helsinn Healthcare SA | 1 |
| NantCell, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 16 |
| Pain | 4 |
| Cancer Pain | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Chronic Pain | 3 |
| Primary Myelofibrosis | 2 |
| Agnosia | 1 |
| Anemia | 1 |
| Cachexia | 1 |
| Endocrine Gland Neoplasms | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.